Sponsor Dossier
Echo Therapeutics
Sponsor Dossier for Echo Therapeutics. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Echo Therapeutics is an Australian Private Company with ABN 92628298699, registered in NSW and currently active.
Portfolio
Echo Therapeutics maintains four brands on the ARTG, all of which are indexable and have Product Information on file. One brand is PBS-listed and two brands have PBAC outcomes on record. Notable brands include BACTRIM, MITOCIN, PEGASYS, and TEMGESIC.
Therapeutic focus
— Infectious Disease: 2 brands — Pain & Anaesthesia: 1 brand — Oncology: 1 brand
PBS footprint
One brand in the Echo Therapeutics portfolio is PBS-listed, with the latest PBS schedule date of 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Echo Therapeutics dates to 1 November 2017, with two brands holding PBAC outcomes on record.